1. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study;Fitzmaurice;JAMA Oncol,2017
2. The efficacy and safety of first-line chemotherapy in advanced esophagogastric cancer: a network meta-analysis;Ter Veer;J Natl Cancer Inst,2016
3. Second- and third-line systemic therapy in patients with advanced esophagogastric cancer: a systematic review of the literature;Ter Veer;Cancer Metastasis Rev,2016
4. Chemotherapy for advanced gastric cancer;Wagner;Cochrane Database Syst Rev,2017
5. Prognostic factors versus predictive factors: examples from a clinical trial of erlotinib;Clark;Mol Oncol,2008